pyrroles and azd2014
pyrroles has been researched along with azd2014 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bolin, S; Brunner, A; Čančer, M; Cho, YJ; Hutter, S; Jones, DT; Kawauchi, D; Kool, M; Korshunov, A; Malyukova, A; Pfister, SM; Rosén, G; Sangfelt, O; Savov, V; Spruck, C; Sundström, A; Suryo Rahmanto, A; Swartling, FJ; Taylor, MD; Weishaupt, H | 1 |
| Jeong, BC; Kim, H; Lee, IK; Lee, J; Lee, SJ; Min, SC; Park, SH; Sung, HH | 1 |
Other Studies
2 other study(ies) available for pyrroles and azd2014
| Article | Year |
|---|---|
FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma.
Topics: Aniline Compounds; Animals; Benzamides; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Chromones; Cisplatin; F-Box Proteins; F-Box-WD Repeat-Containing Protein 7; Glycogen Synthase Kinase 3; HEK293 Cells; Humans; Medulloblastoma; Mice, Nude; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles; SOX9 Transcription Factor; TOR Serine-Threonine Kinases; Ubiquitin-Protein Ligases; Ubiquitination | 2016 |
Synergistic Effects of Combination Therapy with AKT and mTOR Inhibitors on Bladder Cancer Cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Epithelial-Mesenchymal Transition; Humans; Imidazoles; Inhibitory Concentration 50; Morpholines; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles; Quinolines; Signal Transduction; TOR Serine-Threonine Kinases; Urinary Bladder Neoplasms | 2020 |